VITA 34 Second Quarter 2024 Earnings: €0.10 loss per share (vs €0.07 loss in 2Q 2023)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 01 2024
0mins
Source: Yahoo Finance
Key Financial Results: VITA 34 reported a revenue of €19.5 million for Q2 2024, marking a 6% increase from the previous year, but also experienced a net loss of €1.41 million, which is a 19% increase in losses compared to Q2 2023.
Future Outlook and Risks: The company anticipates an average revenue growth of 3.3% per annum over the next three years, slightly below the 3.7% forecast for the German healthcare industry, while also highlighting two warning signs that investors should be aware of.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
